Insider · CIK 0001910644
Nicole Murphy
Files at BIIB (BIOGEN INC.). First filing Feb 17, 2026, latest Feb 17, 2026.
In brief
Nicole Murphy files SEC Form 4 as officer at BIIB (BIOGEN INC.). Since Feb 17, 2026, Nicole Murphy has reported 1 open-market buy worth $585 and 0 open-market sells worth $0, the latest filed on Feb 17, 2026.
A track record needs three past buys with six months of prices behind them; Nicole Murphy has 0, so none is measured yet.
The newest scored trade: bought $585 of BIIB on Feb 12, 2026, filed Feb 17, 2026, scored 10 (weak). In the last 12 months: 1 buy worth $585 and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BIIB: BIOGEN INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 10Weak | BIIBbuy BIOGEN INC. | $585 3 shares | +0% | +72% from low-3% from high |
Transactions
Every row this insider has filed, 39 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | BIIB BIOGEN INC. | POpen-market purchase Common Stock | +3 | $195.04 | $585 | 19,611 | Feb 17, 2026 |
| Feb 13, 2026 | BIIB BIOGEN INC. | AGrant or award Restricted Stock Unitderivative | +10,560 | $0.00 | $0 | 10,560 | Feb 17, 2026 |
| Feb 6, 2026 | BIIB BIOGEN INC. | MOption exercise Common Stock | +2,102 | $0.00 | $0 | 16,324 | Feb 10, 2026 |
| Feb 6, 2026 | BIIB BIOGEN INC. | FTax withholding Common Stock | -1,017 | $201.18 | $205k | 15,307 | Feb 10, 2026 |
| Feb 6, 2026 | BIIB BIOGEN INC. | MOption exercise Common Stock | +1,940 | $0.00 | $0 | 17,247 | Feb 10, 2026 |
| Feb 6, 2026 | BIIB BIOGEN INC. | FTax withholding Common Stock | -914 | $201.18 | $184k | 16,333 | Feb 10, 2026 |
| Feb 6, 2026 | BIIB BIOGEN INC. | MOption exercise Common Stock | +4,683 | $0.00 | $0 | 21,016 | Feb 10, 2026 |
| Feb 6, 2026 | BIIB BIOGEN INC. | FTax withholding Common Stock | -1,408 | $201.18 | $283k | 19,608 | Feb 10, 2026 |
| Feb 6, 2026 | BIIB BIOGEN INC. | MOption exercise Restricted Stock Unitderivative | -2,102 | $0.00 | $0 | 0 | Feb 10, 2026 |
| Feb 6, 2026 | BIIB BIOGEN INC. | MOption exercise Restricted Stock Unitderivative | -1,940 | $0.00 | $0 | 1,940 | Feb 10, 2026 |
| Feb 6, 2026 | BIIB BIOGEN INC. | MOption exercise Restricted Stock Unitderivative | -4,683 | $0.00 | $0 | 9,367 | Feb 10, 2026 |
| Feb 10, 2025 | BIIB BIOGEN INC. | MOption exercise Common Stock | +2,272 | $0.00 | $0 | 14,725 | Feb 12, 2025 |
| Feb 10, 2025 | BIIB BIOGEN INC. | FTax withholding Common Stock | -670 | $142.54 | $96k | 14,055 | Feb 12, 2025 |
| Feb 10, 2025 | BIIB BIOGEN INC. | MOption exercise Restricted Stock Unitderivative | -2,272 | $0.00 | $0 | 0 | Feb 12, 2025 |
| Feb 7, 2025 | BIIB BIOGEN INC. | MOption exercise Common Stock | +2,102 | $0.00 | $0 | 11,736 | Feb 10, 2025 |
| Feb 7, 2025 | BIIB BIOGEN INC. | FTax withholding Common Stock | -620 | $141.35 | $88k | 11,116 | Feb 10, 2025 |
| Feb 7, 2025 | BIIB BIOGEN INC. | MOption exercise Common Stock | +1,940 | $0.00 | $0 | 13,056 | Feb 10, 2025 |
| Feb 7, 2025 | BIIB BIOGEN INC. | FTax withholding Common Stock | -603 | $141.35 | $85k | 12,453 | Feb 10, 2025 |
| Feb 6, 2025 | BIIB BIOGEN INC. | AGrant or award Restricted Stock Unitderivative | +14,050 | $0.00 | $0 | 14,050 | Feb 10, 2025 |
| Feb 7, 2025 | BIIB BIOGEN INC. | MOption exercise Restricted Stock Unitderivative | -2,102 | $0.00 | $0 | 2,102 | Feb 10, 2025 |
| Feb 7, 2025 | BIIB BIOGEN INC. | MOption exercise Restricted Stock Unitderivative | -1,940 | $0.00 | $0 | 3,880 | Feb 10, 2025 |
| Apr 1, 2024 | BIIB BIOGEN INC. | MOption exercise Common Stock | +240 | $0.00 | $0 | 9,751 | Apr 3, 2024 |
| Apr 1, 2024 | BIIB BIOGEN INC. | FTax withholding Common Stock | -117 | $214.83 | $25k | 9,634 | Apr 3, 2024 |
| Apr 1, 2024 | BIIB BIOGEN INC. | MOption exercise Restricted Stock Unitderivative | -240 | $0.00 | $0 | 0 | Apr 3, 2024 |
| Feb 16, 2024 | BIIB BIOGEN INC. | MOption exercise Common Stock | +856 | $0.00 | $0 | 9,624 | Feb 21, 2024 |
| Feb 16, 2024 | BIIB BIOGEN INC. | FTax withholding Common Stock | -414 | $219.08 | $91k | 9,210 | Feb 21, 2024 |
| Feb 16, 2024 | BIIB BIOGEN INC. | MOption exercise Common Stock | +404 | $0.00 | $0 | 9,614 | Feb 21, 2024 |
| Feb 16, 2024 | BIIB BIOGEN INC. | FTax withholding Common Stock | -196 | $219.08 | $43k | 9,418 | Feb 21, 2024 |
| Feb 16, 2024 | BIIB BIOGEN INC. | MOption exercise Performance Stock Unitderivative | -856 | $0.00 | $0 | 0 | Feb 21, 2024 |
| Feb 16, 2024 | BIIB BIOGEN INC. | MOption exercise Restricted Stock Unitderivative | -404 | $0.00 | $0 | 504 | Feb 21, 2024 |
| Feb 16, 2024 | BIIB BIOGEN INC. | JOther Restricted Stock Unitderivative | -504 | $0.00 | $0 | 0 | Feb 21, 2024 |
| Feb 9, 2024 | BIIB BIOGEN INC. | MOption exercise Common Stock | +2,272 | $0.00 | $0 | 9,529 | Feb 13, 2024 |
| Feb 9, 2024 | BIIB BIOGEN INC. | FTax withholding Common Stock | -761 | $240.98 | $183k | 8,768 | Feb 13, 2024 |
| Feb 9, 2024 | BIIB BIOGEN INC. | MOption exercise Restricted Stock Unitderivative | -2,272 | $0.00 | $0 | 2,272 | Feb 13, 2024 |
| Feb 8, 2024 | BIIB BIOGEN INC. | MOption exercise Common Stock | +2,101 | $0.00 | $0 | 7,895 | Feb 9, 2024 |
| Feb 8, 2024 | BIIB BIOGEN INC. | FTax withholding Common Stock | -638 | $240.30 | $153k | 7,257 | Feb 9, 2024 |
| Feb 7, 2024 | BIIB BIOGEN INC. | AGrant or award Restricted Stock Unitderivative | +5,820 | $0.00 | $0 | 5,820 | Feb 9, 2024 |
| Feb 8, 2024 | BIIB BIOGEN INC. | MOption exercise Restricted Stock Unitderivative | -2,101 | $0.00 | $0 | 4,204 | Feb 9, 2024 |
| Jan 29, 2024 | BIIB BIOGEN INC. | AGrant or award Performance Stock Unitderivative | +856 | $0.00 | $0 | 856 | Jan 31, 2024 |
Questions about Nicole Murphy
Answered from the filings on this page, as of the latest one.
Is Nicole Murphy buying or selling?
In the last 12 months Nicole Murphy reported 1 open-market buy worth $585 and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $585 of BIIB on Feb 12, 2026. Grants, option exercises and tax withholding are not counted.
How did Nicole Murphy's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Nicole Murphy has 0.
Where does Nicole Murphy file Form 4?
Nicole Murphy has filed Form 4 at BIIB (BIOGEN INC.) as Head of Pharm Ops and Tech. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.